Kingdon Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-505,729	Closed	-$9.36M	–	65
2019 Q3	$9.36M	Sell	505,729 -325,092	-39%	-$5.98M	1.41%	36
2019 Q2	$15.4M	Sell	830,821 -257,345	-24%	-$5.14M	2.01%	22
2019 Q1	$26.6M	Buy	1,088,166 +27,396	+3%	+$717K	3.78%	8
2018 Q4	$27.5M	Buy	1,060,770 +263,148	+33%	+$7.24M	4.79%	5
2018 Q3	$25.2M	Sell	797,622 -11,231	-1%	-$418K	2.34%	16
2018 Q2	$31.4M	Sell	808,853 -857,376	-51%	-$27.3M	2.7%	8
2018 Q1	$46M	Sell	1,666,229 -63,428	-4%	-$1.44M	3.96%	2
2017 Q4	$31.3M	Sell	1,729,657 -280,668	-14%	-$4.58M	2.76%	10
2017 Q3	$32.5M	Sell	2,010,325 -299,279	-13%	-$4.69M	2.63%	11
2017 Q2	$32M	Sell	2,309,604 -313,114	-12%	-$4.54M	2.75%	12
2017 Q1	$39.3M	Sell	2,622,718 -190,443	-7%	-$2.64M	2.98%	9
2016 Q4	$36.9M	Buy	2,813,161 +117,164	+4%	+$1.84M	2.55%	15
2016 Q3	$46.5M	Buy	2,695,997 +1,784,890	+196%	+$33.1M	3.05%	9
2016 Q2	$16.4M	Buy	911,107 +478,023	+110%	+$9.33M	1.33%	31
2016 Q1	$8.22M	Sell	433,084 -435,945	-50%	-$8.6M	0.64%	57
2015 Q4	$23.2M	Buy	869,029 +380,374	+78%	+$10.2M	1.74%	23
2015 Q3	$11.9M	Sell	488,655 -333,762	-41%	-$11.1M	0.97%	50
2015 Q2	$25.6M	Buy	822,417 +206,566	+34%	+$3.89M	1.49%	29
2015 Q1	$8.96M	Sell	615,851 -240,000	-28%	-$2.71M	0.54%	75
2014 Q4	$8.61M	Buy	855,851 +172,536	+25%	+$1.41M	0.46%	75
2014 Q3	$5.7M	Buy	683,315 +45,000	+7%	+$419K	0.37%	101
2014 Q2	$7.86M	Buy	638,315 +265,000	+71%	+$3.17M	0.41%	92
2014 Q1	$5.18M	Buy	+373,315	New	+$4.99M	0.36%	105